Science 37 Holdings, Inc.

Science 37 Holdings, Inc. (Nasdaq: SNCE) is a healthcare technology company focused on decentralized clinical trials that completed its SPAC business combination with LifeSci Acquisition 2 Corp in October 2021, sponsored by LifeSci SPAC Sponsor 2, LLC. The company entered the public markets through that 2021 merger, operating a platform that enables fully remote and hybrid clinical research to broaden patient access and accelerate drug development timelines. The S-1/A amendment filed in January 2022 reflects routine post-merger registration activity for the newly listed Nasdaq entity. Sign up on SpacDesk for complete filing history, analytics, and ongoing data on SNCE and the full SPAC universe.